Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlo Mustazza

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Medicinal Research Reviews|January 26, 2010
Development of nociceptin receptor (NOP) agonists and antagonistsCarlo Mustazza, Giuditta Bastanzio
Current Medicinal Chemistry|January 16, 2018
Nociceptin /Orphanin FQ Peptide (NOP) Receptor Modulators: An Update in Structure-Activity RelationshipsCarlo Mustazza, Stefano Pieretti, Francesca Marzoli
Current Medicinal Chemistry|September 28, 2019
Small Molecules with Anti-Prion ActivityCarlo Mustazza, Marco Sbriccoli, Paola Minosi, et al.
Annali Dell'Istituto Superiore Di Sanita|December 22, 2018
The evolution of the illegal market of falsified medicines and the experience of the Italian OMCL: from control to research. EditorialCarlo Mustazza, Maria Cristina Gaudiano, Anna Borioni, et al.
Journal of Pharmaceutical and Biomedical Analysis|April 8, 2016
Screening of preservatives by HPLC-PDA-ESI/MS: A focus on both allowed and recently forbidden compounds in the new EU cosmetics regulationRaffaele Lecce, Luca Regazzoni, Carlo Mustazza, et al.
Archiv Der Pharmazie|January 9, 2007
Synthesis of new 4-heteroaryl-2-phenylquinolines and their pharmacological activity as NK-2/NK-3 receptor ligandsAnna Borioni, Carlo Mustazza, Isabella Sestili, et al.
European Journal of Medicinal Chemistry|February 19, 2011
Synthesis and pharmacological evaluation of bivalent antagonists of the nociceptin opioid receptorMaria Rosaria Del Giudice, Anna Borioni, Giuditta Bastanzio, et al.
Journal of Medicinal Chemistry|February 1, 2008
Synthesis and pharmacological evaluation of 1,2-dihydrospiro[isoquinoline-4(3H),4'-piperidin]-3-ones as nociceptin receptor agonistsCarlo Mustazza, Anna Borioni, Isabella Sestili, et al.
Chemical & Pharmaceutical Bulletin|May 3, 2006
Synthesis and evaluation as NOP ligands of some spiro[piperidine-4,2'(1'H)-quinazolin]-4'(3'H)-ones and spiro[piperidine-4,5'(6'H)-[1,2,4]triazolo[1,5-c]quinazolines]Carlo Mustazza, Anna Borioni, Isabella Sestili, et al.
Bioorganic Chemistry|January 8, 2011
High resolution NMR conformational studies of new bivalent NOP receptor antagonists in model membrane systemsAnna Borioni, Giuditta Bastanzio, Maurizio Delfini, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Medicinal Research Reviews|January 26, 2010
Development of nociceptin receptor (NOP) agonists and antagonistsCarlo Mustazza, Giuditta Bastanzio
Current Medicinal Chemistry|January 16, 2018
Nociceptin /Orphanin FQ Peptide (NOP) Receptor Modulators: An Update in Structure-Activity RelationshipsCarlo Mustazza, Stefano Pieretti, Francesca Marzoli
Current Medicinal Chemistry|September 28, 2019
Small Molecules with Anti-Prion ActivityCarlo Mustazza, Marco Sbriccoli, Paola Minosi, et al.
Annali Dell'Istituto Superiore Di Sanita|December 22, 2018
The evolution of the illegal market of falsified medicines and the experience of the Italian OMCL: from control to research. EditorialCarlo Mustazza, Maria Cristina Gaudiano, Anna Borioni, et al.
Journal of Pharmaceutical and Biomedical Analysis|April 8, 2016
Screening of preservatives by HPLC-PDA-ESI/MS: A focus on both allowed and recently forbidden compounds in the new EU cosmetics regulationRaffaele Lecce, Luca Regazzoni, Carlo Mustazza, et al.
Archiv Der Pharmazie|January 9, 2007
Synthesis of new 4-heteroaryl-2-phenylquinolines and their pharmacological activity as NK-2/NK-3 receptor ligandsAnna Borioni, Carlo Mustazza, Isabella Sestili, et al.
European Journal of Medicinal Chemistry|February 19, 2011
Synthesis and pharmacological evaluation of bivalent antagonists of the nociceptin opioid receptorMaria Rosaria Del Giudice, Anna Borioni, Giuditta Bastanzio, et al.
Journal of Medicinal Chemistry|February 1, 2008
Synthesis and pharmacological evaluation of 1,2-dihydrospiro[isoquinoline-4(3H),4'-piperidin]-3-ones as nociceptin receptor agonistsCarlo Mustazza, Anna Borioni, Isabella Sestili, et al.
Chemical & Pharmaceutical Bulletin|May 3, 2006
Synthesis and evaluation as NOP ligands of some spiro[piperidine-4,2'(1'H)-quinazolin]-4'(3'H)-ones and spiro[piperidine-4,5'(6'H)-[1,2,4]triazolo[1,5-c]quinazolines]Carlo Mustazza, Anna Borioni, Isabella Sestili, et al.
Bioorganic Chemistry|January 8, 2011
High resolution NMR conformational studies of new bivalent NOP receptor antagonists in model membrane systemsAnna Borioni, Giuditta Bastanzio, Maurizio Delfini, et al.
Pageof 2